Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Biodesix Inc., 3 years.
Biodesix Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Biodesix Inc. May 19, 2026100.0%
-
Biodesix Inc. May 23, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 14, 2026 | Disc Medicine Inc. | Open-market sale | −6,257 | $69.24 | $433,235 |
| Apr 13, 2026 | Disc Medicine Inc. | Open-market sale | −400 | $69.00 | $27,600 |
| Feb 25, 2026 | Disc Medicine Inc. | Open-market sale | −353 | $69.06 | $24,378 |
| Feb 18, 2026 | Disc Medicine Inc. | Open-market sale | −3,397 | $65.01 | $220,839 |
| Feb 18, 2026 | Disc Medicine Inc. | Open-market sale | −3,684 | $65.89 | $242,739 |
| Feb 17, 2026 | Disc Medicine Inc. | Open-market sale | −4,075 | $62.86 | $256,155 |
| Feb 10, 2026 | Disc Medicine Inc. | Grant or award | +19,000 | — | — |
| Jul 17, 2025 | Disc Medicine Inc. | Open-market sale | −2,031 | $59.00 | $119,829 |
| Jul 10, 2025 | Disc Medicine Inc. | Open-market sale | −2,000 | $57.50 | $115,000 |
| Jun 16, 2025 | Disc Medicine Inc. | Open-market sale | −2,000 | $52.26 | $104,520 |
| Apr 1, 2025 | Biodesix Inc. | Option exercise | +26,368 | — | — |
| Feb 18, 2025 | Disc Medicine Inc. | Open-market sale | −3,136 | $54.58 | $171,163 |
| Feb 10, 2025 | Disc Medicine Inc. | Grant or award | +36,000 | — | — |
| Feb 7, 2024 | Disc Medicine Inc. | Grant or award | +36,666 | — | — |
| Aug 3, 2023 | Biodesix Inc. | Grant or award | +61,728 | $1.62 | $99,999 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.